Drug packaging is primarily designed to protect the drug from contamination and maintain its stability and integrity.

Paper is not commonly used as a primary packaging material for drugs due to its susceptibility to moisture and contamination.

Drug labels typically include the drug name and strength, dosage and administration instructions, manufacturer and expiration date, and other relevant information.

The NDC number is a unique identifier used to track the distribution of drugs in the United States.

Validation is the process of ensuring that a drug's packaging and labeling meet regulatory requirements and are suitable for their intended use.

The FDA is responsible for regulating drug packaging and labeling in the United States to ensure the safety and efficacy of drugs.

A drug's patient information leaflet provides information about the drug's benefits, side effects, and how to take it.

Relabeling is the process of changing a drug's labeling after it has been approved by regulatory authorities.

A drug's expiration date is intended to ensure the drug's safety and efficacy until that date.

Harmonization is the process of ensuring that a drug's packaging and labeling are consistent across different countries.

A drug's lot number is used to identify the drug's manufacturer, track its distribution, and facilitate product recalls.

Patient-centric packaging, user-friendly labeling, and accessible design are all terms used to describe the process of ensuring that a drug's packaging and labeling are suitable for the intended patient population.

A drug's tamper-evident seal is designed to protect the drug from contamination and ensure its safety and efficacy.

International harmonization is the process of ensuring that a drug's packaging and labeling comply with regulatory requirements in multiple countries.

Unit-dose packaging is designed to improve patient compliance, reduce medication errors, and facilitate drug administration.